Mallinckrodt Stock Price - MNK

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 5.19 ▼ -0.01 (-0.19%)
Company Name Stock Ticker Symbol Market Type
Mallinckrodt Plc MNK NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.04 -0.76% 5.20 5.33 4.91 5.18 5.24 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
45,766 11,632,726 $ 5.16 $ 60,002,074 6,950,138 1.27 - 27.3273
Last Trade Time Type Quantity Stock Price Currency
19:59:42 86 $ 5.19 USD

Mallinckrodt Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 437.29M 84.09M $ -3.61B -42.93 2.40 82.77M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
45.08M $ - 0.00% - -

more financials information »

Mallinckrodt News

Loading Messages....

Latest MNK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.175.753.12014.5713,412,6442.0364.04%
1 Month3.815.753.034.037,200,1431.3936.48%
3 Months2.965.752.683.566,967,5082.2475.68%
6 Months8.298.301.273.388,236,876-3.09-37.27%
1 Year19.9627.32731.275.905,419,358-14.76-73.95%
3 Years50.2455.32451.2716.673,524,634-45.04-89.65%
5 Years105.00134.25991.2732.152,894,794-99.80-95.05%

Mallinckrodt Description

Mallinckrodt PLC is a specialty pharmaceutical company that was spun off from Covidien and historically focused on pain therapeutics. After recently moving its generics business into discontinued operations, Mallinckrodt now focuses entirely on branded drugs following the sale of its nuclear imaging business in 2016. Mallinckrodt's products now span a number of therapeutic areas, but a significant portion focus on hospital and clinical customers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.